Predictors of pregnancy outcome in essential thrombocythemia: A single institution study of 63 pregnancies

European Journal of Haematology

Volumn 82, Issue 5, 2009, Pages 350-353

  Gangat, Naseema ^a   Wolanskyj, Alexandra P ^a   Schwager, Susan ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

JAK2; Myeloproliferative; Pregnancy; Thrombocythemia

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; HYDROXYUREA; INTERFERON; JANUS KINASE 2; PHOSPHORUS;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; GENE MUTATION; HEMATOMA; HUMAN; LEUKOCYTE COUNT; LIVE BIRTH; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIMIGRAVIDA; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ASPIRIN; FEMALE; HUMANS; JANUS KINASE 2; LEUKOCYTE COUNT; MUTATION, MISSENSE; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOCYTHEMIA, ESSENTIAL; YOUNG ADULT;

EID: 64249116813     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01214.x     Document Type: Article

References (12)

1. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008 22 : 14 22.
2. McNally RJ, Rowland D, Roman E, Cartwright RA. Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol 1997 15 : 173 89.
3. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008 6 : 632 7.
4. Elliott MA, Tefferi A. Thrombocythaemia and pregnancy. Best Pract Res Clin Haematol 2003 16 : 227 42.
5. Passamonti F, Randi ML, Rumi E, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V > F) mutation. Blood 2007 110 : 485 9.
6. Vardiman JW, Brunning RD, Harris NL. WHO histological classification of chronic myeloproliferative diseases. In : Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors: Tumors of the Haematopoietic and Lymphoid Tissues. Lyon, France : International Agency for Research on Cancer (IARC) Press, 2001 : 17 44.
7. Tefferi A, Lasho TL, Huang J, Finke C, Mesa RA, Li CY, Wu W, Hanson CA, Pardanani A. Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia 2008 22 : 756 61.
8. Hoagland HC, Silverstein MN. Primary thrombocythemia in the young patient. Mayo Clin Proc 1978 53 : 578 80.
9. Beressi AH, Tefferi A, Silverstein MN, Petitt RM, Hoagland HC. Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Arch Intern Med 1995 155 : 1217 22.
10. Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001 66 : 152 9.
11. Niittyvuopio R, Juvonen E, Kaaja R, Oksanen K, Hallman H, Timonen T, Ruutu T. Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. Eur J Haematol 2004 73 : 431 6.
12. Ellish NJ, Saboda K, O'Connor J, Nasca PC, Stanek EJ, Boyle C. A prospective study of early pregnancy loss. Hum Reprod 1996 11 : 406 12.